SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following FDA approval of its oral Wegovy, making it the first GLP-1 pill for weight management. The community sees this as a major catalyst, providing a convenient alternative to injections and positioning Novo Nordisk with a crucial edge in the rapidly expanding obesity treatment market against rivals like Eli Lilly. Investors are closely watching its market impact.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is experiencing a powerful, near-parabolic rally to fresh all-time highs, fueled by escalating industrial demand from sectors like EV batteries and clean energy, alongside looming Chinese export restrictions tightening global supply. This has sparked intense debate among investors, with many anticipating a monumental short squeeze and continued price discovery, while others caution the asset is severely overbought and due for a significant pullback.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is experiencing a significant surge in interest following announced high-grade silver drill results from its Vortex system, which is a key immediate catalyst. This news, combined with sustained share accumulation by Eric Sprott and a broader bullish sentiment in precious metals markets, is driving community discussions around the stock's future potential. Investors are actively debating the implications of these developments for the company's valuation and trajectory.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X is trending as the community eagerly anticipates its merger with Infleqtion, a key player in neutral-atom quantum technology. Recent catalysts like bullish analyst coverage and new strategic partnerships, particularly in defense and GPS-independent navigation, are fueling discussions that Infleqtion is significantly undervalued compared to its quantum peers, poised for substantial growth post-merger.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is trending due to federal regulatory approval for restarting the Las Flores Pipeline System, a critical development for its California offshore oil assets. This news is widely seen as a major de-risking event, with investors optimistic about bypassing state-level hurdles and the potential for a significant short squeeze. The community is actively discussing substantial upside potential, anticipating the restart of production to drive the stock higher.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies is experiencing intense trading activity and significant volatility, driven by a series of recent partnerships and product developments in its niche flexible thin-film solar technology for space and defense. The community is actively debating its low float and short-squeeze potential, eyeing ambitious price targets, even as historical concerns over dilution lead to polarized sentiment amidst its specialized role in the evolving space energy sector.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros (OMER) is experiencing heightened activity as the biotech community eagerly awaits an imminent FDA decision on Narsoplimab for TA-TMA, a first-in-class treatment for a life-threatening condition with no currently approved therapies. The recent closing of its asset purchase and license agreement with Novo Nordisk, which substantially strengthened its balance sheet and triggered a share repurchase program, has intensified community discussions around potential short squeeze scenarios and the drug's market potential.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience (RGC) is attracting significant attention, fueled by its extremely low share float and substantial insider ownership, which is sparking community discussions about a potential short squeeze. Traders are actively tracking its high cost to borrow and anticipating a surge, drawing comparisons to its past explosive runs despite acknowledged speculative fundamentals.

VisionWave Holdings, Inc. engages in the forefront of revolutionizing defense capabilities by integrating advanced artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. The company was founded on September 3, 2024 and is headquartered in Wilmington, DE.

VisionWave Holdings Inc.

VisionWave Holdings, Inc.

VisionWave Holdings (VWAV) is gaining significant attention following a series of strategic developments in the AI, defense, and drone sectors, including new patent grants for its RF imaging technology and a recent acquisition expanding its autonomous aerial platforms. The community is actively discussing VWAV's potential as an "undiscovered" low-float play, drawing comparisons to larger defense AI firms and anticipating substantial upside. Chatter around abnormal market activity and high short borrowing fees further fuels speculation about volatile price movements.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending following a muted 2026 financial outlook, which projects declines in COVID product sales and impacts from patent expirations. This challenging guidance, coupled with news of a patient death in a hemophilia drug trial, is sparking significant investor frustration and renewed calls for leadership changes. While some community members highlight the attractive dividend and long-term value, many are expressing discontent with the stock's persistent underperformance and its strategy in the competitive obesity market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stock Of The Day: Did D-Wave Quantum Just Break Out?

D-Wave Quantum (QBTS) has broken a resistance level. This means there is a good chance a new uptrend has formed.read more...

D-Wave Quantum (NYSE:QBTS) Shares Gap Down - Time to Sell?

D-Wave Quantum (NYSE:QBTS) Shares Gap Down - What's Next...

<ul class="summary-bullets"><li>Quantum stocks have resumed their rally on renewed institutional validation and retail optimism, even as price swings remain pronounced.</li><li>With scalability and commercialization timelines still uncertain, gains are likely to favor companies that demonstrate more precise execution and stronger strategic partnerships.</li><li>A majority of retail traders are bullish despite the volatility and mixed fundamentals.</li></ul>Quantum computing stocks are surging sharply again, even in the absence of any major industry-shaking news. The renewed enthusiasm seems to be driven less by hard catalysts and more by anticipation, with investors looking ahead to the Consumer Electronics Show 2026, set to kick off on Jan. 6.Adding a spark to the optimism,<a href="https://stocktwits.com/symbol/QBTS">&nbsp;D-Wave Computing</a> said its quantum technology evangelist, Murray Thom, will take the CES stage to showcase a live demo of the company’s award-winning systems, alongside real-world customer success stories, a signal that quantum's promise is inching closer to practical application.Skepticism around the technology’s near-term commercial impact still lingers, but that hasn’t stopped investors from piling into the sector. Most smaller publicly traded quantum companies are now on track for a second straight year of gains. The rally in 2024 was nothing short of spectacular, led by D-Wave, whose shares skyrocketed by more than 1,600%, with much of that surge packed into the final two months of the year.<img src="https://news.stocktwits-cdn.com/QC_2024_gains_png_f17a7c5f0d.webp" alt="QC2024 gains.png">Source: KoyfinThe rally stalled at the start of the year, with most, barring D-Wave, trading in the red until mid-to-early September. Thanks to a recovery, catalyzed by Wall Street’s acknowledgment of the technology’s relevance, and some company-specific updates, the quantum rally reignited. The move since then, however, has been interspersed by pullbacks and recoveries, and the gains haven’t been across the board.<img src="https://news.stocktwits-cdn.com/QC_stock_2025_png_03bb66df16.webp" alt="QC stock 2025.png">Source: Koyfin<h2 class="st-heading-2">Retail Upbeat Rally Will Continue</h2>Despite the volatility in quantum stocks, retail traders largely brace for more gains. An ongoing Stocktwits poll that asked retail users of the platform, “How Will Quantum Computing Stocks Perform in 2026?” found that a majority (51%) expect “strong gains across the sector.” But the view isn’t unanimous. Among the respondents, 13% called for a “sharp decline &amp; reset,” while 7% foresaw flattish performance.A sizeable proportion (29%) of respondents bracing for “selecting, winners, mixed results.” If that is the case, investors are left to contend with the question of which ones will outperform and which will lag.<h2 class="st-heading-2">Drawing Strategic Spotlight</h2>Before assessing specific stocks, here’s Wall Street’s crystal-ball view of the industry.The strongest validation from Wall Street firms came in the form of a key development. JPMorgan included quantum computing in the list of industries critical to the national economy. In a statement released in mid-October, the firm said it will make direct equity and venture capital investments of up to $10 billion to help select companies primarily in the United States enhance their growth, spur innovation, and accelerate strategic manufacturing.”&nbsp;Separately, Morgan Stanley disclosed a 7% stake in&nbsp;<a href="https://stocktwits.com/symbol/IONQ">IonQ</a> in August.&nbsp;The Trump administration also took cognizance of the industry's prospects and its critical nature. A Wall Street Journal report, citing sources, stated in late October that the government is mulling small investments in quantum computing names, although no confirmation has come yet.&nbsp;Privately held Quantinium, formed in 2021 through the merger of Cambridge Quantum Computing and Honeywell Quantum Solutions, was in the news following the unveiling of its Helios quantum computer. The company has also forged partnerships to foray into the Middle East, especially Qatar and the UAE.&nbsp;McKinsey estimates that quantum computing, quantum communication, and quantum sensing — the three pillars of the technology — would together generate up to $97 billion in worldwide revenue by 2035, a quantum leap from $4 billion in 2024.Matt Kinsella, CEO of Infleqtion, another privately held quantum computing name, which has agreed to merge with Churchill Capital Corp X (CCCX), a SPAC,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/infleqtion-s-ceo-sees-industry-consolidation-160-b-opportunity/cLPQ4R0REEy">outlined</a> these multiple opportunities in an interview with Stocktwits in November. Infleqtion specializes in quantum sensors used in quantum clocks, RF antennas, gravimeters, and other inertial sensing equipment.<h2 class="st-heading-2">The Pushbacks&nbsp;</h2>The technology itself faces hurdles—including qubit instability, the need for fault-tolerant architectures, limited coherence times, and complex error-correction requirements—that continue to constrain scalability, practical applications, and reliability.&nbsp;Kinsella said the wait for commercially viable computers may not be far off. The executive said it might take until 2028 for Infleqtion to go to 100 logical qubits, which are error-corrected physical qubits.&nbsp; This is when quantum computers will begin to do what classical computers can’t do, he added.<h2 class="st-heading-2">Which is most profitable to buy?</h2>According to Koyfin, the upside potential relative to the average analyst price targets for the publicly listed names is as follows:<figure class="table" style="width:98.32%;"><table class="ck-table-resized"><colgroup><col style="width:32.02%;"><col style="width:10.84%;"><col style="width:10.09%;"><col style="width:16.02%;"><col style="width:31.03%;"></colgroup><tbody><tr><td>&nbsp;</td><td>Upside Potential</td><td>Analyst Coverage</td><td>Proportion of bullish analysts</td><td>Retail Sentiment*</td></tr><tr><td>D-Wave</td><td>+21%</td><td>14</td><td>93%</td><td>Bullish</td></tr><tr><td>IONQ</td><td>+39%</td><td>12</td><td>75%</td><td>Bullish</td></tr><tr><td>Rigetti</td><td>+42%</td><td>11</td><td>73%</td><td>Extremely bullish</td></tr><tr><td>Quantum Computing</td><td>+38%</td><td>4</td><td>50%</td><td>Neutral</td></tr></tbody></table></figure>*based on the Stocktwits sentiment meterWhile broad-based gains may prove elusive, select names with clearer commercialization pathways and strategic backing are likely to drive performance into 2026. It should be noted that these companies are up against big techs, some of which have amped up their bets on quantum computing. IBM, considered a pioneer, is still in the fray, while Microsoft and Alphabet have unveiled in-house quantum chips, and Google has launched an algorithm called “Quantum Echoes.”Infleqtion’s Kinsella also raised the possibility of an industry shakeout&nbsp;in the Stocktwits interview. “I think you'll probably end up with a handful of very large, very important quantum companies over the course of the next five to 10 years,” he said.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/how-amd-quietly-beat-nvidia-this-year-despite-china-curbs/cLepizeREuO">How AMD Quietly Beat Nvidia This Year — Even As China Curbs Hit Them Both</a>

Most smaller publicly traded quantum companies are now on track for a second straight year of gains.

The Quantum Trade Is Heating Up Again — And Retail Thinks 2026 Could Be The Real Payoff

Quantum computing stocks remain volatile and speculative, but rising institutional validation and sustained retail optimism suggest the sector’s rally still has legs.

QTUM, RGTI, QBTS Stocks Have A Santa Rally: Retail Thinks 2026 May Deliver Real Quantum Payoff 

Equity

Quantum computing stocks remain volatile and speculative, but rising institutional validation and sustained retail optimism suggest the sector’s rally still has legs.


Novo Nordisk, Starfighters Space, D-Wave Quantum, Sidus Space And ZIM Integrated Shipping: Why These 5 Stocks Are On Investors' Radars Today

Why 2026 Could Be the Year D-Wave Breaks Out

Despite more than tripling in value in the last year, D-Wave Quantum could continue its upward path into 2026. Is now the time to load up on shares...

Stock Market Today, Dec. 22: D-Wave Quantum Jumps After Announcing CES 2026 Commercial Technology Showcase

D-Wave Quantum (NYSE:QBTS), a quantum computing systems and services developer, closed Monday's session at $32.1, up 19.71%. D-Wave Quantum IPO'd in 2020 and has grown 216% since going public...

D-Wave Quantum (NYSE:QBTS) Trading 19.8% Higher - Here's What Happened

D-Wave Quantum (NYSE:QBTS) Trading 19.8% Higher - Should You Buy...

Value Stocks To Keep An Eye On - December 22nd

Invesco QQQ, Rocket Lab, CoreWeave, D-Wave Quantum, and ProShares UltraPro Short QQQ are the five Value stocks to watch today, according to MarketBeat's stock screener tool. Value stocks are shares...

Promising Quantum Computing Stocks To Watch Now - December 22nd

D-Wave Quantum, IonQ, and Quantum Computing are the seven Quantum Computing stocks to watch today, according to MarketBeat's stock screener tool. Quantum computing stocks are shares of publicly...

Quantum Stocks 2026: Can IONQ & QBTS Follow NVDA's Playbook?

IonQ and D-Wave are gaining momentum in 2026 as quantum computing attracts billions in public and corporate funding.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

Strong Gains Across the Sector

Selective Winners, Mixed Results

Mostly Flat

Sharp Decline & Reset

Quantum computing stocks remain one of the most polarizing areas of the market heading into 2026. Bulls see a transformational technology nearing commercialization, while skeptics point to long timelines, high cash burn, and lofty valuations. With investor opinions sharply divided, how do you expect quantum computing stocks as a sector to perform in 2026?

How Will Quantum Computing Stocks Perform in 2026?

Stocktwits

Stocktwits Polls

The stock's dramatic volatility is a major talking point, with traders noting "comical" daily movements like 20% up followed by 10-15% down.

Discussions focus heavily on specific price points like $26, $29, $29.25, and $30 as critical support, resistance, or targets for short-term movements.

Many users are sharing their strategies, from taking quick profits and cashing out gains (up to 14.5% in a day) to buying puts and averaging down.

Despite short-term price action, a segment of the community discusses the long-term potential of quantum AI, with some seeing it as the "future" coming in 2026, while others debate its viability against industry giants.

QBTS
D-Wave Quantum Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest QBTS News

QBTSD-Wave Quantum Inc